ACTide by Nubilaria against COVID-19

Nubilaria against COVID-19

Important announcement for Researchers and Health Professionals in Europe who want to contribute to the battle against COVID-19: a strong acceleration of research to gain knowledge and facts is needed.

Nubilaria ACTide EDC, our web platform ready for:

  • Agile collection of clinical data (intervention and real-world trials, or epidemiological surveys)
  • Remote patients monitoring
  • Ad hoc collaborative process related to the dramatic increase in off label protocols, intensive therapies and transfer of patients to other hospitals

We currently manage clinical trials, registries, DTP (Diagnostic and Therapeutic Protocols for Clinical Governance), ePROs, workflows for drug supply management.  ACTide counts 2000+ Users in Italy and European countries: Doctors, Patients / Caregivers, Hospital Pharmacists, Logistic Operators, CRO / Pharmaceutical Industries.

We would be glad to support your project, fast track guaranteed and special pricing for non-profit organizations.

We are ready to help. Contact us

 

2020-04 update: DECEIVER trial for COVID-19 related ARDS intensive care: Yghea and Nubilaria happy to donate project management and the eClinical platform.

 

The Nubilaria Team